Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction (original) (raw)
Effect of statin therapy prior to elective percutaneous coronary intervention on frequency of periprocedural myocardial injury
Vijay Gulati
The American Journal of Cardiology, 2004
View PDFchevron_right
The efficacy of statin administration prior to elective PCI in reducing the incidence of post-procedural myocardial infarction or all-cause mortality: a systematic review
FAHAD MOHAMMAD
Res Medica, 2017
View PDFchevron_right
Predictors of coronary intervention-related myocardial infarction in stable angina patients pre-treated with statins
Martin Malý, Pavel Červinka, Josef Veselka
Archives of Medical Science, 2011
View PDFchevron_right
Clinical Benefit of Statin Pretreatment in Patients Undergoing Percutaneous Coronary Intervention
Vincenzo Pasceri
Circulation, 2011
View PDFchevron_right
Effect of Previous Treatment With Statins on Outcome of Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention
David Brosh
The American Journal of Cardiology, 2009
View PDFchevron_right
Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention
deepak bhatt
Acc Current Journal Review, 2002
View PDFchevron_right
Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. The ROMA II trial
Massimo Mancone, Mauro Pennacchi
International Journal of Cardiology, 2013
View PDFchevron_right
Pre-procedural statin use in patients undergoing percutaneous coronary intervention
Milan Seth
American Heart Journal, 2014
View PDFchevron_right
Effect of statin pretreatment on the outcome of ST-segment elevation myocardial infarction in patients without prior history of coronary artery disease
Dennis Cokkinos
Hellenic journal of cardiology : HJC = Hellēnikē kardiologikē epitheōrēsē
View PDFchevron_right
Preprocedural statin therapy, inflammation and myocardial injury in low-risk stable coronary artery disease patients submitted to coronary stent implantation
Márcio Santos
Catheterization and Cardiovascular Interventions, 2013
View PDFchevron_right
Impact of Chronic Pre-Treatment of Statins on the Level of Systemic Inflammation and Myocardial Perfusion in Patients Undergoing Primary Angioplasty
Akin Izgi
The American Journal of Cardiology, 2011
View PDFchevron_right
Effect of seven-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following percutaneous coronary intervention in patients receiving long-term statin therapy. A randomized study
Martin Malý
International Journal of Cardiology, 2013
View PDFchevron_right
Clinical Benefit of Statin Pretreatment in Patients Undergoing Percutaneous Coronary Intervention: A Collaborative Patient-Level Meta-Analysis of 13 Randomized …
Germano Sciascio
Circulation, 2011
View PDFchevron_right
Pre-loading therapy with statins in patients with angina and acute coronary syndromes undergoing PCI
Antonis Manolis
Journal of Interventional Cardiology, 2017
View PDFchevron_right
Meta-Analysis of the Role of Statin Therapy in Reducing Myocardial Infarction Following Elective Percutaneous Coronary Intervention
Henri Roukoz
The American Journal of Cardiology, 2007
View PDFchevron_right
Preprocedural statin therapy reduces the risk and extent of cardiac biomarker release following percutaneous coronary intervention
Josef Veselka
Heart and Vessels, 2006
View PDFchevron_right
Can a high reloading dose of atorvastatin prior to percutaneous coronary intervention reduce periprocedural myocardial infarction?
Akbar Shafiee
View PDFchevron_right
Relation of Troponin I Levels Following Nonemergent Percutaneous Coronary Intervention to Short- and Long-Term Outcomes
Geoffrey Bergman
The American Journal of Cardiology, 2009
View PDFchevron_right
Infarction of a Single High Loading Dose of Atorvastatin on Periprocedural Myocardial Novel Approaches for Preventing or Limiting Events (Naples) II Trial: Impact
Matteo Montorfano
2000
View PDFchevron_right
Statins and Their Role in Pre-Percutaneous Coronary Intervention
Germano Sciascio
Current Cardiology Reports, 2010
View PDFchevron_right
Reduction of Peri - Procedural Myocardial injury by Loading dose of Atorvastatin during Elective Percutaneous Coronary Intervention
Solaiman hossain
View PDFchevron_right
Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study
William J van Gaal, Roberto Violini, italo porto
European Heart Journal, 2005
View PDFchevron_right
Impact on Prognosis of Periprocedural Myocardial Infarction after Percutaneous Coronary Intervention
P. Omede
Journal of Interventional Cardiology, 2014
View PDFchevron_right
Review: Percutaneous coronary interventions and statins therapy
Germano Sciascio
Therapeutic Advances in Cardiovascular Disease, 2008
View PDFchevron_right
Incidence and determinants of myocardial infarction following percutaneous coronary interventions according to the revised Joint Task Force definition of troponin T elevation
George Lau
International Journal of Cardiology, 2010
View PDFchevron_right
Usefulness of Statin Pretreatment to Prevent Contrast-Induced Nephropathy and to Improve Long-Term Outcome in Patients Undergoing Percutaneous Coronary Intervention
Germano Sciascio
The American Journal of Cardiology, 2008
View PDFchevron_right
Isolated Elevation in Troponin T After Percutaneous Coronary Intervention Is Associated With Higher Long-Term Mortality
Mandeep Singh
Journal of The American College of Cardiology, 2006
View PDFchevron_right